NHMRC commits over $6.7 million to medical research into MS
6 October 2021
Over $6.7 million dollars will be invested into MS research by the National Health and Medical Research Council (NHMRC) in their funding scheme.
Over $6.7 million dollars will be invested into MS research by the National Health and Medical Research Council (NHMRC) in their funding scheme.
The Federal Health Minister has announced the listing of Kesimpta® (ofatumumab) on the PBS for the treatment of relapsing remitting MS.
His Excellency General the Honourable David Hurley AC DSC (Retd), the Governor-General of Australia, generously gifted a special medallion to MS Australia to award someone who has contributed to our work in significant way.
Australia’s largest ever Paralympic Games team included three athletes living with multiple sclerosis; Emily Petricola, Carol Cooke and Janine Watson.
The Accessible Product Design Alliance is highlighting the struggle with inaccessible products and packaging, experienced by people living with disability.
New research from the Australian National University (ANU) explores the experiences of people with MS accessing healthcare during the COVID-19 pandemic.
Two months ago Catherine’s life changed completely when she was diagnosed with multiple sclerosis, since then she has raised $2,838 to power MS research.
CEO Rohan Greenland, gives an update on the MS Australia activities for September, focusing on the COVID-19 pandemic and its effect on the MS community.
A recent Australian study examined specific effects of vitamin D on immune cells, towards finding new ways to harness vitamin D for MS therapy.